Qualifications:

- Bachelor of Pharmacy, 1985, Tripoli, Libya,

- Graduate Diploma in Toxicology, 1989, Uppsala, Sweden,

- Dr. Med. Sci. (Ph.D.) in Pharmacology, 1992, Uppsala, Sweden.

Appointments:

  Pharmacist, 1985-1986, NPC, Tripoli, Libya,

  Demonstrator in Pharmacology, 1986-1988, Faculty of Pharmacy, Tripoli,

  Assistant Researcher in Pharmacology, 1992, BMC, Uppsala, Sweden,

  Visiting Scientist in Pharmacology 1993-1994, BMC, Uppsala,

  Lecturer in Pharmacology, 11-1992, Faculty of Pharmacy, Tripoli,

  Head of Department of Pharmacology, 1994-1997, Tripoli,

  Head of Postgraduate studies, 1999-2006, Faculty of Pharmacy, Tripoli,

  Professor of Pharmacology, 1999, Faculty of Pharmacy, Tripoli.

Memberships: 

  Membership of the United Kingdom Clinical Pharmacy Association (UK),

  Membership of the Society of Neuroscience (USA),

  Associate Membership of the European Brain and Behavior Society,

  Membership of the European Behavioral Pharmacology Society,

  Membership of the Scientific Advisory committee for Mediterranean Epilepsy,

  Member of the editorial committee of Journal for Basic and Applied Sciences.

List of Publications (full length articles & communications):

  Sherif F.M., Eriksson L. and Oreland L.: GABA-transaminase activity in rat and human brain; regional, age and sex-related differences.      Journal of Neural Transmission (General Section) 84, 1-2: 95-102; 1991.

  Sherif F.M., Lِofberg C. and Oreland L.: Rat and human brain gamma-aminobutyrate aminotransferase (GABA-T) activities are differently influenced by albumin. In: European Society for Neurochemistry, 8^th meeting, p-75, July 23-28, 1990, Leipzig, Germany.

  Sherif F.M., Marcusson J. and Oreland L.: Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) activities in suicide victims. In: Proceedings for the Scandinavian Physiological Society Meeting in Uppsala, Sweden, May 24-26, 1991, Acta Physicologica Scandinavica, 143, 1: 49A; 1991.

  Sherif F.M., Marcusson J. and Oreland L.: Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims. European Archives of Psychiatry and Clinical Neurosciences 241, 3: 139-144; 1991.

  Sherif F.M., Gottfries C.G., Alafuzoff I. and Oreland L.: Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. Journal of Neural Transmission (Parkinson's Disease and Dementia Section) 4, 3: 227-240; 1992.

  Sherif F.M., Eriksson L. and Oreland L.: Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients. Journal of Neural Transmission (General Section) 90, 3: 231-240; 1992.

  Sherif F.M., Hallman J. and Oreland L.: Low platelet gamma-aminobutyrate aminotransferase and monoamine oxidase activities in chronic alcoholic patients. Alcoholism: Clinical and Experimental Research 16, 6: 1014-1020; 1992.

  Sherif F.M.: A biochemical and clinical study of GABA-transaminase and monoamine oxidase activities in the brain and blood platelets. Acta Universitatis Upsaliensis, Abstr. Upps. Dies. Fac. Med. 342: 1992.

  Sherif F.M. and Oreland L.: Studies on gamma-aminobutyrate aminotransferase (GABA-T) activities in human and rodent brain homogenates. Archives Internationales de Physiologie, de Biochimie et de Biophsysique 100: 361-367; 1992.

  Sherif F.M.: A biochemical and clinical study of GABA-transaminase and monoamine oxidase activities in the brain and blood platelets. Thesis. Acta Universitatis Upsaliensis 342: pp.1-48; 1992, ISBN 91-554-288I-9, Uppsala, Sweden.

  Sherif F.M., Jossan S. and Oreland L.: Gamma-aminobutyrate aminotransferase activity (GABA-T) in blood platelets of six species. Comparative Biochemistry and Physiology 104C, 2: 345-349; 1993.

  Sherif F.M.: GABA-transaminase in brain and blood platelets: basic and clinical aspects: a review. Progress in Neuro-psychopharmacology and Biological Psychiatry 18, 8: 1219-1233; 1994.

  Sherif F.M., Wahlstrom G. and Oreland L.: Brain GABA-transaminase (GABA-T) activity after chronic ethanol administration in rats. In: International Middle-East Conference on Pharmaceutical Sciences, 1^st meeting, p-102, May 3 -5, 1993, Jordan University of Science, Irbid, Jordan.

  Sherif F.M., Wahlstrom G. and Oreland L.: Brain GABA-transaminase and monoamine oxidase after chronic ethanol treatment in rats. Alcoholism: Clinical and Experimental Research 17, 6: 1313-1318; 1993.

  Sherif F.M., Gomes C. and Oreland L.: Methionine synthase and methionine adenosyltransferase activities in rat brain after ethanol treatment. Pharmacology and Toxicology 73: 287-290; 1993.

  Oreland L., Sherif F.M. and Wahlstrِom G.: Effects of ethanol on GABA-transaminase activity. In: Proceedings for Baltic/Scandinavian Physiology Meeting in Tartu, Estonia, May13-16, 1993, Acta Physiologica Scandinavica, p-15, 149, 2: 25A; 1993.

  Sherif F.M., Wahlstrِom G. and Oreland L.: Increase in brain GABA-transaminase activity after chronic ethanol treatment in rats. Journal of Neural Transmission (General Section) 98, 1: 69-79; 1994.

  Sherif F.M., El-hwuegi A. and Oreland L.: Effect of the GABA-T inhibitor vigabatrin on the rat behavior. In: Jamahirrya's Second Conference on Medical Sciences, p-147, May 8-11, 1994, Health and Drug Research Center, Benghazi, Libya.

  Sherif F.M., El-mgadob Z. and Oreland L.: Effect of vigabatrin (GABA-T inhibitor) on drug-induced convulsions in the rat. The First European Congress of Clinical Neuro-pharmacology. May 12-14, 1994, Freiburg, Germany.

  Sherif F.M., Wahlstrom G. and Oreland L.: Brain GABA-transaminase and monoamine oxidase after chronic ethanol treatment in rats. In: Drug abuse: Current Research on Alcoholism and Drug abuse Dependence, 15, 2: 1994.

  Sherif F.M., Harro J., EI-hwuegi A. and Oreland L.: Anxiolytic-like effect of the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA) on rat exploratory behavior. Pharmacology Biochemistry and Behavior 49, 4: 801-805; 1994.

  Sherif F.M. and Oreland L.: Effects of chronic treatment with the GABA-transaminase inhibitor vigabatrin on exploratory behavior in rats. Behavioral Brain Research 63, 1: 11-15; 1994.

  Sherif F.M. Ahmed S.S. and Eriksson L.: Brain aminobutyrate aminotransferase activity in Alzheimer's disease. Neurodegeneration 4, 1: 114-115; 1995.

  Sherif F.M., Kumlien E., Ge L. and Oreland L.: Platelet and brain GABA-transaminase and monoamine oxidase activities in patients with complex partial seizures. Epilepsy Research 20: 161-170; 1995.

  Sherif F.M. and Ahmed S.S.: Basic aspects of GABA-transaminase in neuropsychiatric disorders: review. Clinical Biochemistry 28, 3: 145-154; 1995.

  Sherif F.M. and Oreland L.: The neurotoxic ibotenic acid an brain GABA-T, MAO and ChAT. In: Jamahirrya's Third Conference on Medical Sciences, p-80, May 31- June 3, 1996, Health and Drug Research Center, Tripoli, Libya.

  Sherif F.M., Abushwereb H., Tawati A. and Oreland L.: Effects of diazepam withdrawal and vigabatrin on exploratory behavior of rats. In: European Winter Conference on brain Research, 15^th meeting EWCBR, March 11-18, 1995, L'Alpe D'Huez, France.

  Muhyaddin M. and Sherif F.M.: Acute vigabatrin-phenobarbitone-interaction in exploratory behavior of rats. In: The 18^th Annual meeting of the European Neuroscience Association, p-20, September 3-7, 1995, Amsterdam, Holland.

  Sherif F.M., El-hwuegi A. and Kumlien E.: Acute vigabatrin-phenobarbitone-interaction on exploratory behavior of the rats. Journal of Euro-Med Pharmacy 1, 3: 18-23; 1996.

  El-hwuegi A., Oreland L. and Sherif F.M.: Rat behavioral changes during dependence and withdrawal from phenobarbitone. Manuscript, submitted for publication, 1996.

  Sherif F.M. and Oreland L.: Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behavior in group-housed and socially-isolated rats. Behavioral Brain Research 72: 135-140; 1996.

  Sherif F.M.: Pharmacological aspects of vigabatrin, review. Libyan Journal of Pharmaceutical Sciences 1: 20-21; 1996.

  Sherif F.M.: Problems and suggestions in loco-motor activity and exploration. Libyan Journal of Pharmaceutical Sciences 1: 17; 1996.

  Sherif F.M., Tawati A.M. and Sharif S.I.: Basic aspects of GABA-transmission in alcoholism with particular reference to GABA-transaminase: a review. European Neuropsychopharmacology 7: 1-7, 1997.

  Sherif F.M.: Vigabatrin in the treatment of drug-induced convulsions in rats. In: The First Scientific Conference for the Arab Society of Pharmacy Colleges, 1^st meeting, oral, p-119, October 13 -15, 1997, Faculty of Pharmacy, Irbid, Jordan.

  Hamuda A.Z. and Sherif F.M.: Effects of histamine-2 Blockers on exploratory behavior of rats. In: The First Scientific Conference for the Arab Society of Pharmacy Colleges, 1^st meeting, p-125, October 13-15, 1997, Faculty of Pharmacy, Irbid, Jordan.

  Sherif F.M. and Eriksson L.: Gamma-aminobutyrate aminotransferase activity in brain of patients with senile dementia of Alzheimer type. Journal of Basic and Applied Sciences 1, 3: 113-125; 1997.

  Sherif F.M. and Oreland L.: Brain GABA-T, MAO and ChAT after lesioning with ibotenic acid. In: The First Mediterranean Neuroscience Conference, 1^st meeting, 96, p-100, September 3-6, 1997, Montepellier, Le Corun, France.

  Sherif F.M., Ahmed S.S. and Mami, M.: Total cholesterol in diabetic Libyans. In: The 7^th Pan Arab Union of Neurological Sciences Conference (PAUNSC), March 1-3, 1997, Riyadh, Saudi Arabia.

  Sherif F.M., El-Kickly R. and Tawati A.: Dose and time-response curve of vigabatrin with phenobarbitone and alcohol. In: European Neuroscience meeting, p-202, June 27– July 1, 1998, ENA, Berlin, Germany.

  Sherif F.M. and Ahmed S.S.: Diabetes and hypertension, letter to the editor for the article published in International Diabetes Digest, 1995; 6: 67-69. Int. Diab. Digest. 8, 1: 5, 1997.

  Sherif F.M., Tawati A., Abushwereb H. and Aburawi S.: Influence of vigabatrin on exploratory behavior in rats upon diazepam withdrawal. Journal of NeuroSciences, 4, 4: 278-283; 1999.

  Sherif F.M.: Total Cholesterol in diabetic Libyans. International Diabetes Digest 9,3: 52; 1999.

  Sherif F.M., Adem A. and Oreland L.: GABA-T, MAO and ChAT activities after lesioning of nucleus basalis magnocellularis with ibotenic acid. Journal of Euro Med Pharmacy 1, 4: 21-25; 1998.

  Al-Taher N., Said W., El-muradi E. and Sherif F.M.: Oral contraceptive use in Libyan women. In: The 5^th Jamahiriya Medical Sciences Conference, p-200, November 9-12, 2001, National Medical Research Center, Al-zawia, Libya.

  Aburawi S.M., Mansour M.E., Tawati, A.M. and Sherif F.M.: Diazepam effect on acetylcholine-induced ileum contraction and drug interaction. In: The 4^th Conference on Pharmaceutical Sciences, p-17, April 18-20, 2003, Faculty of Pharmacy, Tripoli, Libya.

  Elfituri A., Sherif F.M., Elmahaishi M. and Chrystyn H.: New roles of the community pharmacist in medicines supply. In: The 4^th Conference on Pharmaceutical Sciences, p-18, April 18-20, 2003, Faculty of Pharmacy, Tripoli, Libya.

  Aburawi S.M., Altubuly R.A., Mansour G.A., Frieg S.H., Sherif F.M. and Tawati A.M.: Diazepam induced sleep and drug interaction. In: The 4^th Conference on Pharmaceutical Sciences, p-29, April 18-20, 2003, Faculty of Pharmacy, Tripoli, Libya.

  Elfituri A., Sherif F.M., Elmahaishi M. and Chrystyn H.: Hormone replacement therapy and postmenopausal symptoms. In: The 4^th Conference on Pharmaceutical Sciences, p-35, April 18-20, 2003, Faculty of Pharmacy, Tripoli, Libya.

 Elfituri A.A., Sherif F.M., Elmahaishi S.M. and Chrystyn H.: Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal women. Maturitas, European Menopause Journal, 52, 52-59; 2005.

 Elfituri A.A., Sherif F.M., Chrystyn H. and Elmahaishi S.M.: 18-month progestogen – only contraception during breast–feeding in Libyan women. Pan Arab Medical Journal 1, 5: 28-32; 2006.

 Elfituri A.A., Elmahaishi S.M., MacDonald T.H. and Sherif F.M.: Health education in the Libyan Arab Jamahiriya: assessment of future needs. Eastern Mediterranean Health Journal, 12, 2S, 147-56, 2006.

  Alshammaki F.A., Hawisa N.T., Auzi A.A. and Sherif F.M.: Anxiolytic-like effect of Euphorbia dendroides L. In: XXX Conference of Pharmaceutical Sciences, The Pharmaceutical Society of Egypt, p-80, December 19-21, 2006, NASR city, Cairo, Egypt.

  Eltair S.A. and Sherif F.M.: A pharmacological study on the national pharmaceutical list in comparison with the world health organization (WHO) list. Journal of Basic and Applied Sciences, accepted for publication, in press, 1997.

 Hwisa N.T., Auzi A.A. and Sherif F.M.: The antinociceptive of Helichrysum stoechas in experimental animals. Manuscript submitted for publication to Bulletin of Pharmaceutical Sciences, 2007.

 Elfituri A.A., Sherif F.M., Elattug M., Elmahaishi S.M. and Chrystyn H.: Libyan professional opinion about an extended role of the community pharmacy. Manuscript submitted for publication to the Arab Journal of Pharmaceutical Sciences, 2007.

  Tawati A.M. and  Sherif F.M.: Self-medication pattern among Libyans: the pharmacological view. In: 67^th International congress on pharmaceutical sciences (FIP), p-34, September 1-7, 2007, Beijing, China.

   Sherif F.M. and Elfituri A.A.: A study to investigate drug use and misuse in Libya In: 67^th International congress on pharmaceutical sciences (FIP), p-334, September 1-7, 2007, Beijing, China.

Research Activities:

  Neuroscience and Neuro-Psychopharmacology.

Teaching Topics:

  General and Systemic Pharmacology.

Fathi Mohamed Omer Sherif,

Professor of Pharmacology,

Department of Pharmacology,

Faculty of Pharmacy, University of Al-Fateh,

Mobile Phone + 218 91 211 7258

P. O. Box  82 757, Tripoli, Libya,